Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

US shortage of Adderall is due to increased demand, FDA and drug-makers say

FDA says supply does not meet demand and drug-maker says backorders are due to ‘significant rise’ in prescription rates

The Guardian - US

The FDA has officially declared a shortage of Adderall

The FDA has confirmed the nation is experiencing a shortage of Adderall after many pharmacies around the country have been unable to fill prescriptions and keep up with demand.

WEKU

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Fla. surgeon general's anti-vax warning

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Salon

Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13

Reuters

Benzinga

Just how safe are cosmetics on the European market?

When was the last time you read the ingredient label on a bottle of shampoo? Have you ever sneezed when applying face powder? As you lay on the beach this summer, did you wonder what it was in your sunscreen that blocked the sun’s UV light and protected your skin?

The Conversation

Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression

Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression (TRD),

Benzinga

Read news from The Economist, FT, and more,
with one subscription

FDA authorizes Covid vaccine boosters for children five and above

Moderna vaccine has been approved for children six years and older, while children as young as five can get Pfizer

The Guardian - US

FDA proposes new definition for 'healthy' food, but will it make us healthier?

The U.S. Food and Drug Administration has proposed a new definition for what constitutes "healthy" food, taking a more holistic look at nutrition and food groups instead of focusing solely on a few vitamins, minerals and nutrients.

Tribune News Service

US FDA authorises updated booster for children aged 5 and older

Bivalent booster is to increase protection for children as US restrictions ease, schools resume in-person learning.

Al Jazeera

Cannabis Chart Of The Week: Biden's Announcement – Stock Market Reactions And A Longer View

Biden's announcement of federal cannabis pardons and a review of the CSA scheduling of cannabis produced a whopping 32.4% pop in the MSOS ETF for the week, easily the largest gain since the ETF was created. After a 10-point retracement, MSOs remain over 20% higher.

Benzinga

Omicron boosters for kids 5-12 are cleared by the CDC

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

WEKU

FDA, CDC authorize COVID-19 Omicron booster shots for kids

The booster shots are now authorized for children as young as 5 years old.

Axios

FDA clears updated COVID boosters for kids as young as 5

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Key Marijuana Executive Changes You Need To Know About: FDA, Humble & More

FDA Names Ex-NY Cannabis Policy Regulator As Advisor On Cannabis Research

Benzinga

European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed

UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used to get the London-based startup fully operational.

Bangkok Post

Häagen-Dazs ice cream worth B12m destroyed

Häagen-Dazs ice cream products worth 12 million baht were destroyed at an industrial facility in Samut Prakan on Monday although their samples were not found to be contaminated with traces of a chemical linked to a cancer.

Orlando Sentinel

Feds rebuke Florida surgeon general’s advice to young men on COVID vaccine

ORLANDO, Fla. — The Food and Drug Administration on Monday responded to the results of Florida Surgeon General Joseph Ladapo’s analysis of COVID-19 data that he says point to a risk for some men who get the shot.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Dow Rises 30 Points; Crude Oil Down 2%

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.

Benzinga

Nasdaq Dips 150 Points; Gold Down 2%

U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.

StockNews.com

2 Top Biotech Stocks to Buy for the Long Haul and 1 to Sell

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…

Reason

New Survey Data Show Adolescent Vaping Remains Far Less Common Than It Was a Few Years Ago

The CDC is still citing underage consumption as a reason to restrict adult access.

Reason

Biden's Marijuana Reforms Are Long Overdue but Will Have Just a Modest Impact

The president's mass pardon does not extend to pot suppliers, and his rescheduling plans won't make marijuana a legal medicine.

The Independent UK

New survey suggests little progress against U.S. teen vaping

The latest government study on teen vaping suggests there’s been little progress in keeping e-cigarettes out of the hands of kids

Reason

The FDA's Perverse Plan To Ban Menthol Cigarettes and Cap Nicotine Levels

The FDA's nicotine restrictions will push consumers toward black-market suppliers, who are completely unconstrained by the FDA’s regulations.

1 … 167 168 169 170

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.